Latest kidney failure Stories
EAST NORRITON, Pa., March 23, 2011 /PRNewswire/ -- Tengion, Inc. (Nasdaq: TNGN), a leader in regenerative medicine, today announced the addition of two renal research and clinical experts, Ben Humphreys, M.D., Ph.D.
The drug rt-PA may prevent infection in kidney dialysis patients, according to a new study.
Mutations in a gene called INF2 are by far the most common cause of a dominantly inherited condition that leads to kidney failure.
EAST NORRITON, Pa., Dec. 7, 2010 /PRNewswire/ -- Tengion, Inc.
Kidney failure affects nearly half a million individuals in the United States, and 48 percent of sufferers are 60 years of age or older.
EAST NORRITON, Pa., Nov. 1, 2010 /PRNewswire-FirstCall/ -- Tengion, Inc. (Nasdaq: TNGN) today provided a business update and reported its financial results for the third quarter ended September 30, 2010.
Elderly patients with kidney failure get kidney transplants more often than they did a decade ago.
In work suggesting a new approach to treating polycystic kidney disease (PKD), a leading cause of kidney failure, researchers at Children's Hospital Boston were able to block the formation of fluid-filled cysts, the hallmark of the disease, in a mouse model.
Aggressive blood sugar control does not improve survival in diabetic patients with kidney failure.
Chronic kidney disease affects millions in North America, with persons of African heritage being at a four-fold higher risk and those of Hispanic heritage having a two-fold higher risk compared to the rest of the population.